Quick Answer
XORTX Therapeutics Inc. reported Total Assets of $2.68 million for fiscal year 2025.
XORTX Therapeutics Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $2.68M -34.5% |
$4.09M -25.1% |
$5.47M -55.8% |
$12.37M -28.8% |
$17.38M +658.9% |
$2.29M |
| R&D Expense | $574.9K +212.8% |
$183.8K -92.4% |
$2.42M -64.2% |
$6.76M +897.9% |
$677.6K +144.2% |
$277.5K +595.4% |
- XORTX Therapeutics Inc. reported Total Assets of $2.68 million for fiscal year 2025.
- XORTX Therapeutics Inc. showed a decrease of -34.5% in Total Assets compared to the prior fiscal year.
- XORTX Therapeutics Inc. reported R&D Expense of $574.9 thousand for fiscal year 2025.
- XORTX Therapeutics Inc. showed an increase of +212.8% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: